샘플 요청 목록

 카트 문의
시장보고서
상품코드
1559638

세계 RSV 진단 시장

RSV Diagnostics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 233 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

RSV 진단 세계 시장은 2030년까지 12억 달러에 달할 전망

2023년에 7억 6,840만 달러로 추정된 RSV 진단 세계 시장은 2030년에는 12억 달러에 이르고, 분석 기간 2023-2030년의 CAGR은 6.9%로 성장할 것으로 예측됩니다. RSV 진단 키트 및 분석은 본 보고서에서 분석한 부문 중 하나이며 CAGR은 7.7%로 성장을 지속하고, 분석 기간이 끝날 때 6억 8,660만 달러에 달할 것으로 예측됩니다. RSV 진단 기기 분야의 성장률은 분석 기간 동안 CAGR 6.3%로 추정됩니다.

미국 시장은 2억 350만 달러로 추정, 중국은 CAGR 11.6%로 성장 예측

미국 RSV 진단 시장은 2023년 2억 350만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 3억 580만 달러 규모에 이를 것으로 예측되며 분석 기간 2023-2030년 CAGR은 11.6%입니다. 다른 주목할만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 2.7%와 7.0%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 3.7%로 성장할 것으로 예측됩니다.

세계 RSV 진단 시장 - 주요 동향 및 촉진요인 요약

RSV 진단이란 무엇이며 왜 공중 보건에 중요한가? 호흡기 합포체 바이러스(RSV) 진단에는 폐와 호흡기에 감염을 일으키는 일반적인 호흡기 바이러스 인 RSV의 존재 검출을 위한 다양한 검사 및 조치가 포함됩니다. RSV는 유아, 유아, 노인, 면역 결핍에 특히 위험하며 기관지염과 폐렴과 같은 심각한 호흡기 질환을 유발합니다. 조기 및 정확한 진단은 바이러스의 확산을 방지하고 시기 적절한 개입을 가능하게 하기 때문에 효과적인 관리와 치료에 매우 중요합니다. RSV 진단에는 중합효소 연쇄반응(PCR)과 같은 분자검사, 항원검출검사, 혈청학적 검사가 포함되며, 각각 감도, 특이도, 소요시간이 다릅니다. RSV가 사회적 약자에게 미치는 영향에 대한 인식이 높아짐에 따라 효율적이고 신속한 진단 솔루션에 대한 수요는 임상과 POC 모두에서 증가하고 있습니다.

기술 발전은 RSV 진단 시장을 어떻게 형성하는가?
기술의 진보는 RSV 진단의 정확성, 속도 및 접근성을 높이는 데 매우 중요한 역할을 합니다. 몇 분 안에 결과를 얻을 수 있는 신속 항원 검사의 개발은 POC(Point of Care) 진단에 혁명을 가져오고, RSV 검사를 외래나 응급 의료 현장에서 보다 이용하기 쉽게 하고 있습니다. 분자진단, 특히 실시간 PCR과 핵산 증폭 검사(NAAT)의 진보는 더 높은 감도와 특이성을 제공하고 시료에서 낮은 바이러스 양의 검출을 가능하게합니다. RSV와 인플루엔자 및 COVID-19와 같은 다른 호흡기 병원체를 동시에 검사할 수 있는 멀티플렉스 패널의 도입은 진단 효율을 향상시키고 종합적인 호흡기 질환 관리를 가능하게 합니다. 게다가 디지털 플랫폼과 원격 의료의 사용은 원격 진단 및 진단을 용이하게 하고 환자의 치료에 대한 접근성을 향상시킵니다. 이러한 기술 혁신은 RSV 진단의 적용 범위와 효능을 확대하고 첨단 지역과 개발 도상 지역 모두에서 채택을 촉진하고 있습니다.

RSV 진단 시장에는 어떤 과제와 기회가 존재합니까?
RSV 진단 시장은 고급 진단 검사 비용이 높고, 검사 정확도의 변동, 복잡한 진단 장비를 운영하는 숙련자의 필요성 등 여러 과제에 직면하고 있습니다. PCR과 같은 분자진단 검사는 비용이 높기 때문에 특히 저자원 환경에서는 보급 장벽이 될 수 있습니다. 또한, 다른 검사의 민감도와 특이도의 변동은 위양성과 위음성을 유발하여 임상적인 의사결정에 영향을 미칠 수 있습니다. 그러나 이러한 도전은 성장과 혁신의 큰 기회가 되었습니다. RSV에 대한 인식 증가와 공중 보건에 대한 영향은 세계 호흡기 질환 증가와 함께 효과적이고 저렴한 진단 솔루션에 대한 수요를 촉진하고 있습니다. 조기 발견과 예방 건강 관리에 대한 관심 증가는 시장 잠재력을 더욱 향상시키고 있습니다. 또한 원격 의료 및 원격 진단의 확대는 RSV 진단 제공업체가 혁신적이고 사용하기 쉬운 솔루션을 제공할 수 있는 새로운 기회를 창출하고 있습니다.

RSV 진단 시장의 성장을 견인하고 있는 요인이란?
RSV 진단 시장의 성장은 특히 유아, 노인, 면역결핍 집단에서 RSV 감염의 발생률이 증가하는 등 여러 요인에 의해 견인되고 있습니다. 신속 항원 검사, 실시간 PCR, 멀티플렉스 패널, 디지털 진단의 기술적 진보로 RSV 진단의 정확도, 속도, 접근성이 향상되어 채용이 진행되고 있습니다. 또한 조기 진단, 예방 의료, RSV 및 인플루엔자 및 COVID-19와 같은 다른 호흡기 질환과의 감별 필요성에 대한 관심이 높아지고 있다는 것도 시장 성장에 기여하고 있습니다. 또한, 특히 신흥 시장에서의 의료 인프라의 확대와 1차 케어 환경에서의 포인트 오브 케어 검사의 채용 확대도 RSV 진단 수요를 끌어올리고 있습니다. 환자의 결과를 개선하고, 입원을 줄이고, RSV의 확산을 최소화하는 데 중점을 두는 것이 RSV 진단 시장을 더욱 발전시키고 있습니다.

조사 대상 기업 예(총 166건)

  • Abbott Molecular
  • Apollo Diagnostics
  • Becton, Dickinson and Company
  • Biomeb
  • BIOMED Labordiagnostik GmbH
  • bioMerieux SA
  • Bioperfectus Technologies
  • BioReference Laboratories, Inc.
  • Cellgen Diagnostics
  • Cepheid

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

JHS 24.09.27

Global RSV Diagnostics Market to Reach US$1.2 Billion by 2030

The global market for RSV Diagnostics estimated at US$768.4 Million in the year 2023, is expected to reach US$1.2 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2023-2030. RSV Diagnostics Kits & Assays, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$686.6 Million by the end of the analysis period. Growth in the RSV Diagnostics Instruments segment is estimated at 6.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$203.5 Million While China is Forecast to Grow at 11.6% CAGR

The RSV Diagnostics market in the U.S. is estimated at US$203.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$305.8 Million by the year 2030 trailing a CAGR of 11.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global RSV Diagnostics Market - Key Trends and Drivers Summarized

What Are RSV Diagnostics and Why Are They Critical for Public Health?
Respiratory Syncytial Virus (RSV) diagnostics involve a range of tests and procedures designed to detect the presence of RSV, a common respiratory virus that causes infections in the lungs and respiratory tract. RSV is particularly dangerous for infants, young children, the elderly, and immunocompromised individuals, leading to severe respiratory illnesses such as bronchiolitis and pneumonia. Early and accurate diagnosis is crucial for effective management and treatment, as it helps prevent the spread of the virus and enables timely intervention. RSV diagnostics include molecular tests like Polymerase Chain Reaction (PCR), antigen detection tests, and serological assays, each providing different levels of sensitivity, specificity, and turnaround times. As the awareness of RSV's impact on vulnerable populations grows, the demand for efficient and rapid diagnostic solutions is rising in both clinical and point-of-care settings.

How Are Technological Advancements Shaping the RSV Diagnostics Market?
Technological advancements are playing a pivotal role in enhancing the accuracy, speed, and accessibility of RSV diagnostics. The development of rapid antigen tests that provide results in minutes is revolutionizing point-of-care diagnostics, making RSV testing more accessible in outpatient and emergency care settings. Advances in molecular diagnostics, particularly in real-time PCR and nucleic acid amplification tests (NAATs), are offering higher sensitivity and specificity, allowing for the detection of even low viral loads in samples. The introduction of multiplex panels that can simultaneously test for RSV and other respiratory pathogens, such as influenza and COVID-19, is improving diagnostic efficiency and enabling comprehensive respiratory illness management. Additionally, the use of digital platforms and telemedicine is facilitating remote diagnosis and consultation, enhancing patient access to care. These technological innovations are expanding the scope and effectiveness of RSV diagnostics, driving their adoption in both developed and developing regions.

What Challenges and Opportunities Exist in the RSV Diagnostics Market?
The RSV diagnostics market faces several challenges, including high costs of advanced diagnostic tests, variability in test accuracy, and the need for skilled personnel to operate complex diagnostic equipment. The high cost of molecular diagnostic tests, such as PCR, can be a barrier to widespread adoption, particularly in low-resource settings. Additionally, variations in the sensitivity and specificity of different tests can lead to false positives or negatives, affecting clinical decision-making. However, these challenges present significant opportunities for growth and innovation. The increasing awareness of RSV and its impact on public health, coupled with the rise in global respiratory illnesses, is driving demand for effective and affordable diagnostic solutions. The growing focus on early detection and preventive healthcare is further boosting market potential. Moreover, the expansion of telehealth and remote diagnostics is creating new opportunities for RSV diagnostics providers to offer innovative and accessible solutions.

What Factors Are Driving the Growth of the RSV Diagnostics Market?
The growth in the RSV Diagnostics market is driven by several factors, including the rising incidence of RSV infections, particularly among infants, the elderly, and immunocompromised populations. Technological advancements in rapid antigen tests, real-time PCR, multiplex panels, and digital diagnostics are enhancing the accuracy, speed, and accessibility of RSV diagnostics, driving their adoption. The increasing focus on early diagnosis, preventive healthcare, and the need to differentiate RSV from other respiratory illnesses, such as influenza and COVID-19, is also contributing to market growth. Additionally, the expansion of healthcare infrastructure, particularly in emerging markets, and the growing adoption of point-of-care testing in primary care settings are boosting the demand for RSV diagnostics. The emphasis on improving patient outcomes, reducing hospitalizations, and minimizing the spread of RSV is further propelling the RSV diagnostics market forward.

Select Competitors (Total 166 Featured) -

  • Abbott Molecular
  • Apollo Diagnostics
  • Becton, Dickinson and Company
  • Biomeb
  • BIOMED Labordiagnostik GmbH
  • bioMerieux SA
  • Bioperfectus Technologies
  • BioReference Laboratories, Inc.
  • Cellgen Diagnostics
  • Cepheid

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • RSV Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Early Detection and Diagnosis of Respiratory Syncytial Virus (RSV) Propels Market Growth
    • Increasing Use in Pediatric and Elderly Populations Expands Addressable Market Opportunity
    • Technological Advancements in Molecular and Point-of-Care Diagnostics Strengthen Market Position
    • Growing Focus on Preventing RSV-Related Complications Drives Adoption of Advanced Diagnostics
    • Surge in Demand for Rapid and Accurate RSV Testing Generates New Opportunities
    • Expanding Applications in Outpatient Clinics and Home Testing Throws Spotlight on Market Potential
    • Growth in Awareness and Screening Programs for Respiratory Infections Spurs Demand for RSV Diagnostics
    • Surge in Demand for RSV Testing During Flu Season and Outbreaks Expands Market Horizons
    • Growing Awareness of the Benefits of Early RSV Diagnosis in Reducing Hospitalizations Drives Market Adoption
    • Innovations in Portable and Digital Diagnostic Devices Generate New Market Opportunities
    • Rising Demand for RSV Diagnostics in Hospital and Ambulatory Care Settings Throws Spotlight on Market Dynamics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for RSV Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for RSV Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for RSV Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Kits & Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Kits & Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Kits & Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Rapid Antigen Detection Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Rapid Antigen Detection Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Rapid Antigen Detection Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Other Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World RSV Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • JAPAN
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • CHINA
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • EUROPE
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for RSV Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for RSV Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for RSV Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • FRANCE
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • GERMANY
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for RSV Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for RSV Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for RSV Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • INDIA
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for RSV Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for RSV Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for RSV Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for RSV Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for RSV Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for RSV Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030
  • AFRICA
    • RSV Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for RSV Diagnostics by Product - Kits & Assays, Instruments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for RSV Diagnostics by Product - Percentage Breakdown of Value Sales for Kits & Assays, Instruments and Other Products for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for RSV Diagnostics by Method - Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for RSV Diagnostics by Method - Percentage Breakdown of Value Sales for Molecular Diagnostics, Rapid Antigen Detection Tests and Other Methods for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제